Startups
The Exosome People. PranaX is leveraging the safety and evolving exosome biology to understand their regenerative properties.
Overview
Location
United States
Total raised
$17M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 30, 2026 | PranaX: $17 Million Series A Raised To Expand Exosome Based Regenerative Biologics Platform | PranaX announced it has closed an oversubscribed $17 million Series A financing as the company scales its regenerative biologics work centered on stem cell-derived exosomes. The biotechnology company said the round was led by family offices... |
| Pranax | “PranaX is an innovative health science company with a commitment to pioneering longevity solutions and quality of life advancement.” | |
| Pranax | “The Exosome People. PranaX is leveraging the safety and evolving exosome biology to understand their regenerative properties.” |
Reviews 0
FAQ about PranaX Corporation
How much funding has PranaX Corporation raised?
PranaX Corporation has raised $17M in total across 1 funding round.
What has the press written about PranaX Corporation?
Parsers VC has collected 4 articles mentioning PranaX Corporation, among them “PranaX: $17 Million Series A Raised To Expand Exosome Based Regenerative Biologics Platform” (Jan 30, 2026) and “Pranax”.
Is PranaX Corporation still active?
Yes, PranaX Corporation is active; its latest activity on Parsers VC dates from Feb 2, 2026.